Related Articles
NF-κB inhibitor reverses temozolomide resistance in human glioma TR/U251 cells
miR‑146b‑5p suppresses glioblastoma cell resistance to temozolomide through targeting TRAF6
PomGnT1 enhances temozolomide resistance by activating epithelial-mesenchymal transition signaling in glioblastoma
Forkhead box protein O3a promotes glioma cell resistance to temozolomide by regulating matrix metallopeptidase and β‑catenin
Estrogen receptor β agonist enhances temozolomide sensitivity of glioma cells by inhibiting PI3K/AKT/mTOR pathway